Home
Conditions
Systemic Sclerosis

Clinical trial condition

Systemic Sclerosis

Explore clinical trials studying Systemic Sclerosis. Study availability and eligibility vary by location and protocol.

227 public trials 51 recruiting studies

Refine in advanced search Browse all conditions

Systemic Sclerosis trial results

Not yet recruiting

A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

NCT07212322

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +46 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis

NCT07209644

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

Exploring the Patterns of Sleep Disordered Breathing in Systemic Sclerosis Patients

NCT07175246

Conditions: Apnea, Connective Tissue Diseases, Dyssomnias, +13 more
Locations: Assiut University hospital Asyut, Asyut Governorate, Egypt

View Trial Details

Not yet recruiting

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

NCT06978738

Conditions: ANCA-associated Vasculitis, Anemia, Anemia, Hemolytic, +36 more
Locations: Changzhou No.2 People's Hospital Changzhou, China

View Trial Details

Not yet recruiting

Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT06970951

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +18 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not yet recruiting

89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis

NCT06489652

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

NCT06420154

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +32 more
Locations: The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Enrolling by invitation

A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

NCT07038447

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +21 more
Locations: City of Hope Duarte, California, United States

Stanford University Stanford, California, United States

Tampa General Hospital Cancer Institute Tampa, Florida, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Enrolling by invitation

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

NCT06472362

Conditions: Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations: Bichat-Claude Bernard hospital Paris, France

Hanover Medical School Hanover, Germany

Marche Polytechnic University Ancona, Italy

Sassari University Sassari, Italy

View Trial Details

Enrolling by invitation

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

NCT06888973

Conditions: Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +30 more
Locations: Armed Forces Bone Marrow Transplant Centre/ National Institute of Blood and Marrow Transplant (AFBMTC/NIBMT) Rawalpindi, Pakistan

Pak Emirates Military Hospital Rawalpindi, Pakistan

View Trial Details

Systemic Sclerosis

Systemic Sclerosis trial results

Related conditions